Laurent Degos
Laurent Degos is a prominent French hematologist and oncologist known for his significant contributions to the field of medicine, particularly in the treatment of acute promyelocytic leukemia (APL). He has played a crucial role in advancing medical research and has held various prestigious positions in the medical community.
Early Life and Education[edit | edit source]
Laurent Degos was born in France. He pursued his medical education at the University of Paris, where he specialized in hematology and oncology. His early research focused on the mechanisms of blood diseases and the development of innovative treatments.
Career[edit | edit source]
Degos began his career as a researcher and clinician, quickly gaining recognition for his work in hematology. He has held several key positions, including serving as the head of the Hematology Department at the Saint-Louis Hospital in Paris. His research has been instrumental in the development of new therapies for blood cancers.
Contributions to Medicine[edit | edit source]
One of Degos' most notable achievements is his work on the treatment of acute promyelocytic leukemia (APL). He was a pioneer in the use of all-trans retinoic acid (ATRA) in combination with arsenic trioxide for the treatment of APL, which has significantly improved patient outcomes. This treatment approach has become a standard of care for APL patients worldwide.
Degos has also contributed to the understanding of the genetic and molecular basis of blood diseases. His research has led to the identification of several key genetic mutations associated with various forms of leukemia and other hematologic disorders.
Awards and Honors[edit | edit source]
Throughout his career, Laurent Degos has received numerous awards and honors for his contributions to medicine. He has been recognized by various medical societies and institutions for his groundbreaking research and clinical achievements.
Publications[edit | edit source]
Degos has authored and co-authored numerous scientific papers and articles in prestigious medical journals. His work has been widely cited and has had a significant impact on the field of hematology and oncology.
Related Pages[edit | edit source]
- Hematology
- Oncology
- Acute promyelocytic leukemia
- All-trans retinoic acid
- Arsenic trioxide
- Saint-Louis Hospital
- University of Paris
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
